Trading Sections
AxoGen receives dual analyst support after FDA approval with targets up to $40 (+40 %)
The stock of AxoGen (AXGN) was recently discussed when it broke out to a new multi-year high. The company...
Vera Therapeutics: JPMorgan considers drug in IgA nephropathy potentially strategically attractive - Analyst sees 140% upside potential
Vera Therapeutics (VERA) positions itself as a late-stage biotechnology company focused on the development...
Compass Therapeutics: Canaccord Recommends Buy with Nearly 90% Price Potential!
Compass Therapeutics (CMPX) is a biotech company focused on developing innovative immunotherapies against...
Wells Fargo sees Oracle as a potential leader in the “super-cycle” of AI with 40% upside potential.
There was a Oracle (ORCL) sharp pullback after the up-gap, despite the company not only delivering strong...
Ondas Holdings: Revenue Expected to Increase Tenfold by 2028 – Short Ratio Could Propel the Rally Again After New Drone Contract
Ondas Holdings (ONDS) is gaining momentum after consolidating. The company operates in two segments:...
Boeing secures billion-dollar contracts – Defense business is picking up again. More deliveries and positive free cash flow are expected in 2026.
The shares of Boeing (BA) took a significant hit over the summer following the rally in the second quarter....
Annexon Inc.: Clear Street Initiates Coverage with a Buy Recommendation and 312% Price Potential!
Annexon Inc. (ANNX) (i.) has recently caught our attention due to an analyst's comment after Wells Fargo...
Synopsys: After three years of sideways movement, the stock could regain momentum following NVIDIA's investment.
Synopsys: After three years of sideways movement, the stock could regain momentum following NVIDIA's...
Kratos Defense delivered solid Q3 growth. Following the price decline, B. Riley analysts see a good risk-reward ratio and 35% upside potential
Kratos Defense & Security Solutions (KTOS) is an incredibly important player in the defense sector....
Neumora Therapeutics Inc.: RBC Capital sees 190% Upside Potential!
Neumora Therapeutics Inc. (NMRA) is a biotech company specializing in neuroscience to provide improved...
AI, Security, and Cloud Drive Solid Growth Dynamics: ePlus is Poised for Breakout from the Base
The stock of ePlus (PLUS) is interesting for a breakout from the base, following the momentum from three...
Silver Price Near All-Time High: Silvercorp Metals Has a Moderate P/E Ratio of 12 Despite Rally. The Stock Can Break Out Again.
The stock of Silvercorp Metals (SVM) has undergone a significant rally and is now consolidating at the...
Delivery Hero SE: Pressure from Major Shareholders Fuels Share Price - Barclays Sees Over 86% Price Potential!
In particular, Delivery Hero SE (i.) has stood out positively in the German market on November 28. The...
Exail Technologies: Autonomous Maritime Robotics Drives Orders to Record Levels. The Share Price Decline Offers a new Entry Opportunity.
Exail Technologies is a highly specialized technology company from France, which in 2025 can demonstrate...
Kura Oncology: H.C. Wainwright Reaffirms Buy Recommendation - Inclusion of Komfiziti in National Comprehensive Cancer Network Guidelines Praised
Kura Oncology Inc. (KURA) is a biotechnology company focused on developing precision medicine therapies...
CleanSpark Inc.: H.C. Wainwright Confirms Buy Recommendation - Price Target Reduction Still Implies around 112% Upside Potential
CleanSpark Inc. (CLSK) , a leading player in Bitcoin mining, is in the spotlight for investors following...
Industry and Communication Drive Growth: Analog Devices Ahead of a new all-Time High after the Figures.
Analog Devices (ADI) is a global leader in semiconductor technology that combines analog, digital, AI,...
Autodesk: Quality and Growth Stock in Focus. Over 20% EPS Growth in Q3. The AI-based Feature Sketch AutoConstrain is in High Demand.
Autodesk (ADSK) remains an interesting quality and growth stock. The company operates with SaaS-based...
ArriVent Biopharma: Truist Securities recommends buying with a price target of $43!
ArriVent Biopharma (AVBP) positions itself as a clinical pharmaceutical company committed to the global...
Voyager Technologies: JPMorgan Sees 110 % Price Potential - Additional Space Stations Could Offer Opportunities
Voyager Technologies Inc. (VOYG) positions itself not as a pure aerospace company, but as a technology...
MediWound Ltd.: H.C. Wainwright recommends buying and sees 109% upside potential!
MediWound Ltd. (MDWD) is a biotechnology company specializing in the development and commercialization...
Cipher Mining: Citizens JMP Sees 86% Price Potential, Plus a 10-Year Contract with Fluidstack Has Been Signed!
The Cipher Mining Inc. (CIFR) (i.) is currently undergoing a strategic transformation, positioning the...
Praxis Precision Medicines Inc.: BTIG sees around 130% upside potential for the biotech!
Praxis Precision Medicines (PRAX) is a biopharmaceutical company focused on developing novel therapies...